Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference21 articles.
1. Clinical (Stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients;Aalders;Gynecol. Oncol.,1984
2. The management of Stage III carcinoma ofthe endometrium;Antoniades;Cancer,1976
3. Stage I grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Sites of failure and correlation of failure rate with irradiation technique;Bedwinek;Cancer,1984
4. Stage III adenocarcinoma of the endometrium: two prognostic groups;Bruckman;Gynecol. Oncol.,1980
5. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals;Creasman;Am. J. Obstet. Gynecol.,1981
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study;Gynecologic Oncology;2019-07
2. Temporal trends for adjuvant radiation utilization and their effect on survival for locally advanced (stage III) endometrial cancer in the USA;Journal of Radiation Oncology;2017-05-03
3. No cookie-cutter oncology: individualized treatment approaches for women with corpus endometrial cancer;Expert Review of Anticancer Therapy;2010-07
4. Clinical Applications of Volumetric Modulated Arc Therapy;International Journal of Radiation Oncology*Biology*Physics;2010-06
5. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study;Gynecologic Oncology;2009-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3